Navigation Links
Abbott's m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
Date:10/22/2007

rogression of structural damage and improving physical function in patients with psoriatic arthritis. HUMIRA can be used alone or in combination with methotrexate or other disease-modifying anti- rheumatic drugs (DMARDs). HUMIRA is also approved for reducing signs and symptoms in patients with active ankylosing spondylitis.

Earlier this year, HUMIRA was approved for reducing the signs and symptoms and inducing and maintaining clinical remission in adults with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy, and reducing the signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab.

Clinical trials are currently under way evaluating the potential of HUMIRA in other immune-mediated diseases.

Important Safety Information

Serious infections, sepsis, tuberculosis (TB) and opportunistic infections, including fatalities, have been reported with the use of TNF- blocking agents, including HUMIRA. Many of these serious infections have occurred in patients also taking other immunosuppressive agents that in addition to their underlying disease could predispose them to infections. Infections have also been reported in patients receiving HUMIRA alone. Treatment with HUMIRA should not be initiated in patients with active infections. TNF-blocking agents, including HUMIRA, have been associated with reactivation of hepatitis B (HBV) in patients who are chronic carriers of this virus. Some cases have been fatal. Patients at risk for HBV infection should be evaluated for prior evidence of HBV infection before initiating Humira. The combination of HUMIRA and anakinra is not recommended and patients using HUMIRA should not receive live vaccines.

More cases of malignancies have been observed among patients receiving TNF blockers, including HUMIRA, compared to control patients in clinical trials. These malignancies, other than
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
2. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
4. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
5. DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
6. Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimers Disease Presented at AD/PD Meeting
7. New Advances in Gastric Diagnostics: Smaller is Better
8. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
9. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
10. Non-Invasive Diagnostic Tests for Celiac Disease
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... The North American dermatology diagnostic devices market ... from 2014 to 2019. Although mature markets (the U.S. ... in the dermatology diagnostic devices market, Mexico ... CAGR of 9.8% during the forecast period. The growth ... factors such as rising incidences of skin disorders, increasing ...
(Date:4/21/2015)... Fla. , April 21, 2015   Rock ... drug development company focused on the treatment of chronic ... key independent appointment to the Company,s Board of Directors ... Samuel as a new director. ... of Rock Creek Pharmaceuticals, said, "Dr. Samuel,s experience in ...
(Date:4/21/2015)... -- This report analyzes the worldwide markets for Apheresis ... for Therapeutic Apheresis, and Equipment for Donor Apheresis. Global ... Plateletpheresis, and Others. The report provides separate comprehensive analytics ... Japan , Europe , ... Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology:North American Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019 2North American Dermatology Diagnostic Devices Market by Diagnostic Device, by Treatment Device, by Application - Forecast to 2019 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 2Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 4Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 5Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 6Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 7World Apheresis Equipment Industry 2World Apheresis Equipment Industry 3World Apheresis Equipment Industry 4World Apheresis Equipment Industry 5World Apheresis Equipment Industry 6World Apheresis Equipment Industry 7World Apheresis Equipment Industry 8World Apheresis Equipment Industry 9World Apheresis Equipment Industry 10World Apheresis Equipment Industry 11World Apheresis Equipment Industry 12World Apheresis Equipment Industry 13World Apheresis Equipment Industry 14World Apheresis Equipment Industry 15World Apheresis Equipment Industry 16World Apheresis Equipment Industry 17World Apheresis Equipment Industry 18World Apheresis Equipment Industry 19World Apheresis Equipment Industry 20World Apheresis Equipment Industry 21
... Aug. 2 RoundTable Healthcare Partners ("RoundTable"), ... healthcare industry, announced today that its portfolio company, Aspen ... Bard-Parker ™ surgical blades and scalpels ... a leading manufacturer of disposable medical products with an ...
... SAN DIEGO , Aug. 2 Novalar Pharmaceuticals, Inc., a ... premier pharmaceutical product, has again been selected by leading dental industry magazine ... full results of the 24th annual competition were published in the July ... ...
Cached Medicine Technology:RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business 2RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business 3OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 2OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 3
(Date:4/21/2015)... 2015 Grafika is pleased to announce ... Impressions. , “We’re excited about the acquisition ... capabilities and knowledgeable team members,” according to Bernard Elzer, ... to offer an ever wider breadth of products to ... specialty services we already offer. It also complements ...
(Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
(Date:4/21/2015)... April 21, 2015 The ... provides comparative analysis on the therapeutic development ... by identifying new targets and MOAs to ... with TOC is available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html ... key players involved in the therapeutic development ...
(Date:4/21/2015)... 2015 AvePoint, the established ... today announced a new enhancement to DocAve Policy ... Office 365 Management Activity API. This integration creates a ... and take action on all events that take place ... 365 Management Activity API provides customers with greater transparency ...
(Date:4/21/2015)... April 21, 2015 Catalent (Booth ... technologies and development solutions for drugs, biologics and ... ADVASEPT™ Lock, a stopper-less, glass- and needle-free vial ... medications. Easily opened, ADVASEPT Lock attaches to a ... container closure with the security of an advanced ...
Breaking Medicine News(10 mins):Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2
... COLUMBIA, Mo. Osteoarthritis is commonly diagnosed in the ... expected to decrease pain and slow progression of disease. ... and humans, doctors and veterinarians need a precise way ... of Missouri researchers are investigating potential biomarkers in dogs ...
... , -- New Tissue Dissection System Used by Italian Surgeons ... , PALO ALTO, Calif., June 10 PEAK Surgical, ... System by surgeons in the European Union, where the innovative ... , , Dr. Raul Pellini and Prof. Giuseppe Spriano, ...
... in U.S. Senate & House will help eliminate barriers ... , WASHINGTON, June 10 Late yesterday U.S. ... legislation that will improve access to life-saving diagnostic tests ... Access to Critical Lab Tests Act (S. 1220) will ...
... partners with Canadian Hospital Specialties, to release EchoStim(R) ... , CINCINNATI, June 10 Havel,s Incorporated, ... partnered with CHS, Canadian Hospital Specialties, which will ... EchoBlock(R) Ultrasound Needles throughout Canada. , , ...
... Would Increase Threat of Disease , , PHILADELPHIA, June 10 ... John Hanger today asked Pennsylvanians to make every effort to control ... , Hanger said standing water can quickly become a breeding ... rule of dump it, drain it and treat it. , ...
... June 10 Millennium Research Group (MRG), the global ... the economic downturn, market growth in the European gastrointestinal ... cancer (CRC) screening programs in France, Germany, and the ... European Markets for GI Endoscopy Devices 2009 report, ...
Cached Medicine News:Health News:Early detection of osteoarthritis in dogs could open doors for a cure 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 2Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 3Health News:PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe 4Health News:Legislation Will Expand Access to Life-Saving Laboratory Tests 2Health News:Havel's Incorporated Expands Successful EchoStim(R) Ultrasound Needles into Canada 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 2Health News:DEP Asks Pennsylvanians to Help Battle West Nile Virus 3Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 2Health News:Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: